4. AEGERA: www.aegera.com
Aegera Therapeutics is a clinical stage biotechnology company focused on developing drugs that control apoptosis to address major unmet medical needs. Our lead programs are in development to induce apoptosis to kill cancer cells and to prevent apoptosis to save injured neuronal cells:
• AEG35156 targets the key anti-apoptotic protein XIAP, and is currently in multiple human clinical trials for the treatment of solid tumors and leukemia;
• Aegera is developing potent small molecule IAP inhibitors for the treatment of multiple cancers, inflammatory and autoimmune diseases leveraging our knowledge of and intellectual property on the IAP protein family (Inhibitor of Apoptosis Proteins).
• Aegera also has novel oral small molecules in late stage preclinical development for the treatment of neuropathic pain and neuropathies induced by diabetes or chemotherapy.
Aegera Therapeutics Inc.
810 chemin du Golf
Montreal, Quebec
H3E 1A8 CANADA
Tel: 514.288.5532
Fax: 514.288.9280
